Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J

Effusive Tuberculous Pericarditis

The STS National Database

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,

Amit Iyengar, Christopher N. Scipione, MD, Parth Sheth, Richard G

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Outcomes of Reintervention on the Autograft After Ross Procedure

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery Ming Liu, MS, MA, Charlotte M. Druschel,

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S

Anaerobic Metabolism During Cardiopulmonary Bypass: Predictive Value of Carbon Dioxide Derived Parameters Marco Ranucci, MD, Giuseppe Isgrò, MD, Federica.

Autologous Platelet-Rich Plasma Reduces Transfusions During Ascending Aortic Arch Repair: A Prospective, Randomized, Controlled Trial Shao Feng Zhou,

Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.

Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery Jason Brase, MS, Brooke Finger, MS,

Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V

Denton A. Cooley, August 22, 1920, to November 18, 2016

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients Faraz Kerendi, MD, John D. Puskas,

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Off-Label Use of Recombinant Human Factor VIIa

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation Steven A. Farmer, MD, PhD, Kathleen L. Grady,

Pleural Metastasis of Osteosarcoma

Intrapleural Instillation of Autologous Blood for Persistent Air Leak in Spontaneous Pneumothorax in Patients With Advanced Chronic Obstructive Pulmonary.

Influence of Mechanical Cell Salvage on Red Blood Cell Aggregation, Deformability, and 2,3-Diphosphoglycerate in Patients Undergoing Cardiac Surgery With.

Origins of the Cardiothoracic Surgery Network (CTSNet)

Who Do You Say You Are? The Annals of Thoracic Surgery

Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery Lyndsey J. Bowman, Walter E.

Transthoracic Repair of Slipped Nissen Fundoplications: Technique and Results Ruchir Puri, MD, Adam M. Cline, MD, MS, Daniel T. DeArmond, MD, Scott B.

Saving Lives Is More Important Than Abstract Moral Concerns: Financial Incentives Should Be Used to Increase Organ Donation Benjamin Hippen, MD, Lainie.

Use of Amiodarone After Major Lung Resection

Modified Ross Procedure to Prevent Autograft Dilatation

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemostasis Michael Mazzeffi, MD, MPH, John.

Splenic Rupture Caused by Giant Paraesophageal Hernia

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Acute Aortic Valve Thrombosis Secondary to Recombinant Factor VIIa

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation

Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery Fausto Biancari, MD, PhD, Eeva-Maija.

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

An Unusual Cause of Hemoptysis in a Young Woman

Off-Pump Coronary Artery Bypass Disproportionately Benefits High-Risk Patients John D. Puskas, MD, Vinod H. Thourani, MD, Patrick Kilgo, MS, William Cooper,

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD

Stany Sandrio, MD, Ariawan Purbojo, MD, Robert A

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Greg Stratmann, MD, PhD, Isobel A Russell,

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Dana Y. Fuhrman, DO, MS, Lan G

Invited Commentary The Annals of Thoracic Surgery

Functional and Physiologic Results of Video-Assisted Thoracoscopic Diaphragm Plication in Adult Patients With Unilateral Diaphragm Paralysis Richard.

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Pulmonary Embolectomy for Acute Massive Pulmonary Embolism

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

The Annals of Thoracic Surgery

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Late Consequences of a Much Earlier Decision

An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass

The Impact of New Technology on Cardiothoracic Surgical Practice

Harvey Edward Garrett, MD, Bradley A. Wolf, MD

Presentation transcript:

Prophylactic Use of Factor IX Concentrate in a Jehovah's Witness Patient Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J. Molinaro, PhD, MT, Fania Szlam, MMSc, Edward P. Chen, MD, Kenichi A. Tanaka, MD, MS The Annals of Thoracic Surgery Volume 88, Issue 5, Pages 1666-1668 (November 2009) DOI: 10.1016/j.athoracsur.2009.03.095 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Hemostatic interventions, and changes in hematocrit, platelet count and international normalized ratio. Shaded area represents the duration of cardiopulmonary bypass. (A = antithrombin; B = Bebulin [Baxter Healthcare Corp, Westlake Village, CA]; C = cryoprecipitate; P = protamine; R = re-transfusion of autologous blood; rFVIIa = recombinant factor VIIa [Novoseven; NovoNordisk, Bagsbaerd, Denmark]). The Annals of Thoracic Surgery 2009 88, 1666-1668DOI: (10.1016/j.athoracsur.2009.03.095) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions